Proprietary Cytotoxic Payloads
- Next-generation cytotoxins
Eribulin Drug Conjugate*:
- Eribulin (Halaven®), the payload
- In preclinical studies, the ADC format exhibited:
- Potent antitumor activity
- Good safety profile
* Any antibody drug conjugate (ADC) employing eribulin as a payload is investigational and has not been approved by regulatory authorities. For information on Halaven® (eribulin mesylate), please see the package insert or contact Eisai’s Medical Information toll-free number 1.888.274.2378.